Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-17

FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Bisoprolol Fumarate and Hydrochlorothiazide from ANI Pharmaceuticals, resulting in an updated approval under the sup…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bisoprolol Fumarate and Hydrochlorothiazide (bisoprolol fumarate and hydrochlorothiazide)

Snippet

SUPPL AP for BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE)